Telesis Bio, Inc (TBIO) Cash Funds per Single Share

Symbol and logo of brand Telesis Bio, Inc (TBIO)

Telesis Bio, Inc. (TBIO) operates in an autonomous cycle, remaining a defensive asset regardless of the global economy. The cash per share trend captures the rate of resource consumption, while the value of 5.80 shows the most recent figure. Telesis Bio, Inc. (TBIO) is implementing DNA/mRNA synthesis automation, leveraging the growth of the gene therapy market. Consumables sales and partnerships with pharma behemoths will serve as the primary catalysts.

Cash per Single Share: Codex DNA (TBIO) for 04/28/2023 - 10/05/2024

Comprehensive metric breakdowns and analytics for Telesis Bio (TBIO)

- market value and analyst target forecast:
- cash and cash flow data:
Summary company analysis:Telesis Bio, Inc.
Finished products of telesisbio.com

Bioprinter patents require significant expenditures to integrate equipment into laboratory cycles. This metric determines the share of liquid assets per common share of Telesis Bio, Inc. (TBIO), reflecting the company's actual cash reserves. An increase in this indicator reduces bankruptcy risk, although excess funds may signal inefficient capital management. Analyzing this trend allows for an assessment of the issuer's financial stability. Track the cash per share to monitor solvency.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|BLUE (bluebirdbio.com) - Cash per Share|Cash on Hand per Share ImmunoPrecise Antibodies IPA|Cash per Single Share OMGA (omegatherapeutics.com)|Cash per Share Singular Genomics Systems, Inc. (OMIC)|Cash per Share RGLS (Regulus Therapeutics, Inc.)|Cash per Share Syros SYRS|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology